REV1 and neoplasm: That also explains that the effects of REV1 on the occurrence, development, prognosis and drug sensitivity of tumors vary greatly among different tumor types and different SNPs, which reminds us that REV1, as a novel biomarker and potential therapeutic target, requires specific analysis of specific problems.